Middle East & Africa PCR Technologies Market
The Middle East & Africa PCR Technologies Market size was valued at US$ 626.35 Mn in 2022 and is projected to reach US$ 1,057.27 Mn by 2030, growing at a CAGR of 6.8% during 2022 - 2030.
Report Coverage
- Technology: Real-Time PCR, Conventional PCR, Reverse Transcription PCR, Digital PCR, Multiplex RT PCR, Hot Start PCR
- Offerings: Reagents & Consumables, Instruments, Software & Services
- End User: Hospitals & Diagnostic Centers, Academia & Research Institutes, Pharmaceutical & Biotechnology Companies
US$ 626.35 Mn
Market size in 2022
US$ 1,057.27 Mn
Market Size by 2030
6.8%
CAGR, 2022 - 2030
2023-2030
Forecast Period
1. Introduction
1.1 Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Market Insights
2.2 Market Attractiveness
3. Research Methodology
3.1 Secondary Research
3.2 Primary Research
- 3.2.1 Data Triangulation and Validation
4. Middle East & Africa PCR Technologies Market Landscape
4.1 Overview
4.3 Ecosystem Analysis
- 4.3.1 List of Vendors in the Value Chain
5. Middle East & Africa PCR Technologies Market – Key Market Dynamics
5.1 Market Drivers
5.2 Market Restraints
5.3 Market Opportunities
5.4 Future Trends
5.5 Impact of Drivers and Restraints
6. Middle East & Africa PCR Technologies Market Regional Analysis
6.2 Middle East & Africa PCR Technologies Market Revenue 2020-2030 (US$ Million)
6.3 Middle East & Africa PCR Technologies Market Forecast Analysis
7. Middle East & Africa PCR Technologies Market Analysis – by Technology
7.1 Real-Time PCR
- 7.1.1 Overview
- 7.1.2 Real-Time PCR: Middle East & Africa PCR Technologies Market – Revenue and Forecast, 2020-2030 (US$ Million)
7.2 Conventional PCR
- 7.2.1 Overview
- 7.2.2 Conventional PCR: Middle East & Africa PCR Technologies Market – Revenue and Forecast, 2020-2030 (US$ Million)
7.3 Reverse Transcription PCR
- 7.3.1 Overview
- 7.3.2 Reverse Transcription PCR: Middle East & Africa PCR Technologies Market – Revenue and Forecast, 2020-2030 (US$ Million)
7.4 Digital PCR
- 7.4.1 Overview
- 7.4.2 Digital PCR: Middle East & Africa PCR Technologies Market – Revenue and Forecast, 2020-2030 (US$ Million)
7.5 Multiplex RT PCR
- 7.5.1 Overview
- 7.5.2 Multiplex RT PCR: Middle East & Africa PCR Technologies Market – Revenue and Forecast, 2020-2030 (US$ Million)
7.6 Hot Start PCR
- 7.6.1 Overview
- 7.6.2 Hot Start PCR: Middle East & Africa PCR Technologies Market – Revenue and Forecast, 2020-2030 (US$ Million)
8. Middle East & Africa PCR Technologies Market Analysis – by Offerings
8.1 Reagents & Consumables
- 8.1.1 Overview
- 8.1.2 Reagents & Consumables: Middle East & Africa PCR Technologies Market – Revenue and Forecast, 2020-2030 (US$ Million)
8.2 Instruments
- 8.2.1 Overview
- 8.2.2 Instruments: Middle East & Africa PCR Technologies Market – Revenue and Forecast, 2020-2030 (US$ Million)
8.3 Software & Services
- 8.3.1 Overview
- 8.3.2 Software & Services: Middle East & Africa PCR Technologies Market – Revenue and Forecast, 2020-2030 (US$ Million)
9. Middle East & Africa PCR Technologies Market Analysis – by End User
9.1 Hospitals & Diagnostic Centers
- 9.1.1 Overview
- 9.1.2 Hospitals & Diagnostic Centers: Middle East & Africa PCR Technologies Market – Revenue and Forecast, 2020-2030 (US$ Million)
9.2 Academia & Research Institutes
- 9.2.1 Overview
- 9.2.2 Academia & Research Institutes: Middle East & Africa PCR Technologies Market – Revenue and Forecast, 2020-2030 (US$ Million)
9.3 Pharmaceutical & Biotechnology Companies
- 9.3.1 Overview
- 9.3.2 Pharmaceutical & Biotechnology Companies: Middle East & Africa PCR Technologies Market – Revenue and Forecast, 2020-2030 (US$ Million)
10. Middle East & Africa PCR Technologies Market – Middle East and Africa Analysis
10.1 Overview
10.2 Middle East and Africa- 10.2.1 Middle East & Africa PCR Technologies Market Breakdown, by Key Country, 2023 and 2030 (%)
- 10.2.1.1 Middle East & Africa PCR Technologies Market – Revenue and Forecast Analysis – by Country
- 10.2.1.1 South Africa: Middle East & Africa PCR Technologies Market – Revenue and Forecast to 2030 (US$ Million)
- 10.2.1.1.1 South Africa: Middle East & Africa PCR Technologies Market Breakdown, by Technology
- 10.2.1.1.2 South Africa: Middle East & Africa PCR Technologies Market Breakdown, by Offerings
- 10.2.1.1.3 South Africa: Middle East & Africa PCR Technologies Market Breakdown, by End User
- 10.2.1.2 Saudi Arabia: Middle East & Africa PCR Technologies Market – Revenue and Forecast to 2030 (US$ Million)
- 10.2.1.2.1 Saudi Arabia: Middle East & Africa PCR Technologies Market Breakdown, by Technology
- 10.2.1.2.2 Saudi Arabia: Middle East & Africa PCR Technologies Market Breakdown, by Offerings
- 10.2.1.2.3 Saudi Arabia: Middle East & Africa PCR Technologies Market Breakdown, by End User
- 10.2.1.3 UAE: Middle East & Africa PCR Technologies Market – Revenue and Forecast to 2030 (US$ Million)
- 10.2.1.3.1 UAE: Middle East & Africa PCR Technologies Market Breakdown, by Technology
- 10.2.1.3.2 UAE: Middle East & Africa PCR Technologies Market Breakdown, by Offerings
- 10.2.1.3.3 UAE: Middle East & Africa PCR Technologies Market Breakdown, by End User
- 10.2.1.4 Rest of Middle East and Africa: Middle East & Africa PCR Technologies Market – Revenue and Forecast to 2030 (US$ Million)
- 10.2.1.4.1 Rest of Middle East and Africa: Middle East & Africa PCR Technologies Market Breakdown, by Technology
- 10.2.1.4.2 Rest of Middle East and Africa: Middle East & Africa PCR Technologies Market Breakdown, by Offerings
- 10.2.1.4.3 Rest of Middle East and Africa: Middle East & Africa PCR Technologies Market Breakdown, by End User
11. Competitive Landscape
11.1 Heat Map Analysis
11.2 Company Positioning and Concentration
12. Industry Landscape
12.1 Overview
12.2 Market Initiative
12.3 Partnerships and Collaborations
12.4 Other Developments
13. Company Profiles
13.1 Thermo Fisher Scientific Inc
- 13.1.1 Key Facts
- 13.1.2 Business Description
- 13.1.3 Products and Services
- 13.1.4 Financial Overview
- 13.1.5 SWOT Analysis
- 13.1.6 Key Developments
13.2 Promega Corp
- 13.2.1 Key Facts
- 13.2.2 Business Description
- 13.2.3 Products and Services
- 13.2.4 Financial Overview
- 13.2.5 SWOT Analysis
- 13.2.6 Key Developments
13.3 QIAGEN NV
- 13.3.1 Key Facts
- 13.3.2 Business Description
- 13.3.3 Products and Services
- 13.3.4 Financial Overview
- 13.3.5 SWOT Analysis
- 13.3.6 Key Developments
13.4 bioMerieux SA
- 13.4.1 Key Facts
- 13.4.2 Business Description
- 13.4.3 Products and Services
- 13.4.4 Financial Overview
- 13.4.5 SWOT Analysis
- 13.4.6 Key Developments
13.5 Hoffmann-La Roche Ltd
- 13.5.1 Key Facts
- 13.5.2 Business Description
- 13.5.3 Products and Services
- 13.5.4 Financial Overview
- 13.5.5 SWOT Analysis
- 13.5.6 Key Developments
13.6 Bio-Rad Laboratories Inc
- 13.6.1 Key Facts
- 13.6.2 Business Description
- 13.6.3 Products and Services
- 13.6.4 Financial Overview
- 13.6.5 SWOT Analysis
- 13.6.6 Key Developments
13.7 Becton Dickinson and Co
- 13.7.1 Key Facts
- 13.7.2 Business Description
- 13.7.3 Products and Services
- 13.7.4 Financial Overview
- 13.7.5 SWOT Analysis
- 13.7.6 Key Developments
13.8 Takara Bio Inc
- 13.8.1 Key Facts
- 13.8.2 Business Description
- 13.8.3 Products and Services
- 13.8.4 Financial Overview
- 13.8.5 SWOT Analysis
- 13.8.6 Key Developments
13.9 Standard BioTools Inc
- 13.9.1 Key Facts
- 13.9.2 Business Description
- 13.9.3 Products and Services
- 13.9.4 Financial Overview
- 13.9.5 SWOT Analysis
- 13.9.6 Key Developments
13.10 Ellume Ltd
- 13.10.1 Key Facts
- 13.10.2 Business Description
- 13.10.3 Products and Services
- 13.10.4 Financial Overview
- 13.10.5 SWOT Analysis
- 13.10.6 Key Developments
14. Appendix
14.1 About Business Market Insights
14.2 List of Abbreviations
Access the Full M Market Report
Get segment-level forecasts, regional estimates, competitive benchmarking, company profiles and downloadable Excel datasets.
